Neck Pain and Botox Injections

Added 21 Jul, 2017 [ssba]


The patient presented with chronic neck pain of more than 6 years duration. The pain was mainly one sided, with radiation to the shoulder blade. The patient also experienced significant headaches from the neck pain. She was unable to carry on with her job in the retail sector. She was very low in her mood because of the intensity of her pain.


The patient had seen various specialists in the past including physiotherapists, osteopaths, chiropractors and the musculoskeletal team. She was investigated with an MRI scan which showed degenerative changes in the discs and osteoarthritis in the little joints of the neck (Cervical facet joints).

The patient was taking a cocktail of medications including Amitriptyline, Co-codamol, Tramadol, and Paracetamol without benefit.


The patient saw Dr. Krishna at his private clinic in Bristol, desperate for a treatment of her neck pain. Dr. Krishna felt that the pain was mainly myofascial and offered trigger point injections with Botox under real-time ultrasound guidance, targeting the trapezius muscles in the neck.

The patient had an excellent response to Botox trigger point injections and was almost completely pain-free within a week.


At the follow-up appointment 4 months after the injection, the patient reported continued benefit from the Botox injections. Her mood was much better and she was back to work. She cut down on her pain killers significantly and had not seen her GP for several months now.

For further information please contact us at


Have a question? Or would like to book in with us?

Get in Touch

Common Conditions
that we Treat Everyday

View All Conditions

Latest from the Blog

Posted 07 Feb, 2019

Stellate Ganglion Block a Potential Lifesaver in Severe PTSD

Case reports are mounting of immediate, durable, and significant relief of severe refractory symptoms of posttraumatic stress disorder (PTSD), according to an anesthesiologist who has seen the benefits firsthand. Stellate ganglion blockade (SGB) “seems to significantly improve PTSD symptoms as well as significant...
Posted 25 Jan, 2019

CGRP Antagonists: A new era for migraine treatment

Migraine is a common medical condition, affecting as many as 37 million people in the US. It is considered a systemic illness, not just a headache. Recent research has demonstrated that changes may begin to occur in the brain as long as 24 hours before migraine symptoms begin. Many patients have a severe throbbing head...